-
Colombian judge bans strikes on guerrillas if minors are present
-
Carreras reverts to fullback as Argentina change four for Australia Test
-
Khachanov shocks ailing Auger-Aliassime, Swiatek and Osaka advance at US Open
-
Wilson back to lead Australia as Kiss rotates team for Argentina
-
Lone juror blocking verdict in US mother's child murder trial: defense
-
Yen surges on new intervention talk, US stocks rally
-
'Kinda chic' - Williams sisters set to launch US Open doubles bid
-
Japan's Ueda fires Lille top of Ligue 1 on debut
-
Volkswagen says cutting 100,000 jobs by end of decade
-
Arsenal chief executive reveals 'dynasty' ambition
-
Russia slaps curfew on charity director over army criticism
-
Spanish PM says no 'solid proof' Morocco planned migrant rush
-
Ailing Auger-Aliassime upset by Khachanov at US Open
-
Iran war is not a war, US VP Vance says
-
Richarlison omitted from Tottenham's Premier League squad
-
Khachanov stuns third-seeded Auger-Aliassime in US Open second round
-
How El Nino is choking the Panama Canal
-
Bordeaux facing sixth-tier football after French federation upholds relegation
-
Hamilton drives his Ferrari dream at Monza
-
Stoic Verstappen looking beyond 'painful' Monza weekend
-
Senegal has an IMF loan, now what?
-
OpenAI begins rollout of new powerful AI model GPT-6 Astra
-
Auger-Aliassime upset by Khachanov at US Open
-
FIFA blasts UEFA 'smear campaign,' fights World Cup plan disclosures
-
Hugging Face, the French start-up that became AI's warehouse
-
Zelensky hopes to host US envoys in Kyiv in 'coming days'
-
World Cup winner Llorente retires from Spain team at 31
-
Martinelli joins Al-Hilal from Arsenal for reported £60 million
-
Osaka squeezes into US Open third round
-
Tesla's semi-autonomous driving could be adapted to EU norms: France
-
Apple faces £2 bn lawsuit in UK over app privacy feature
-
37 people die from fumes during oil pipeline theft in Nigeria: NGO
-
Former champ Swiatek eases into US Open third round
-
Ahead of elections, Israel tests West's patience on West Bank violence
-
DR Congo latest to promise moving Israel embassy to Jerusalem
-
Antonelli will obey Mercedes orders to help 'tow' teammate Russell
-
War criminal Mladic's body returns to Serbia with military honours
-
UK fintech Revolut gains conditional US banking licence
-
Pierre Cardin museum brings designer's futurist style to Venice
-
Mara sisters channel childhood energy for twins performance at Venice
-
Slovenian rookie Omrzel triumphs as Mas extends Vuelta lead
-
UN's Sudan probe says foreign fighters fuelling conflict
-
British, French leaders talk migrants, EU relations
-
Violence erupts at S.Africa anti-migrant protest
-
Heading for Ferrari's home race, Leclerc still dreams of world title
-
Nothing left: Nepal flood survivors face loss and uncertainty
-
Cafe at centre of Israel culture clash agrees to shut on Sabbath
-
Tesla to launch self-driving 'Cybercab' in Texas
-
Spacecraft bound for Mercury begins 'tricky' arrival
-
Europe struggles to respond as Russia escalates shadow warfare
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
F.Müller--BTB